Comparison Overview

Drug Interactions from The Medical Letter

VS

EMJ

Drug Interactions from The Medical Letter

145 Huguenot St, None, New Rochelle, New York, US, 10801
Last Update: 2025-11-27
View Profile
Between 750 and 799
http://www.medicalletter.org/LIDIOE

Drug Interactions from The Medical Letter®—from the company you trust for unbiased drug information. Drug Interactions Are Preventable. With Drug Interactions from The Medical Letter®, clinicians can easily search for, quickly find, and prevent potentially life-threatening interactions between drugs. Some features of our new, continuously-updated database include: - Over 43,000 monographs describing interactions between prescription drugs, over-the-counter drugs, herbs, supplements, and lifestyle factors such as smoking and alcohol use - Trusted recommendations about how best to avoid or manage potential interactions - Information about whether other drugs in the same class or drugs used for the same indication could interact in a similar way - Intuitive online user interface that is optimized for delivery on your mobile device Subscribe to Drug Interactions from The Medical Letter - http://www.medicalletter.org/LIDIOE

NAICS: 511
NAICS Definition: Publishing Industries (except Internet)
Employees: None
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0
View Profile

EMJ

88 Wood Street, London, Greater London, EC2V 7RS, GB
Last Update: 2025-11-23
Between 750 and 799
http://www.emjreviews.com/

EMJ is the number one open access destination for HCPs and Pharma professionals globally. We do this across 18 therapy areas and the pharmaceutical sector via EMJ GOLD. We use industry-leading digital tools, to meet the challenges of time-poor medical professionals with a real passion to learn and in turn to elevate the quality of healthcare globally. Our content builds trust between healthcare professionals and Pharma, to help them continuously improve together. At the core of our content hub is a portfolio of peer reviewed, open access journals, which are complemented by alternative formats such as interviews, podcasts, webinars, and infographics. We have built our incredible team by recruiting on values. We stay true to these values in everything we do, as we remain steadfast in our goal to create Gold Medal Winners. For trusted partners who share our vision, we invite you to get in touch and join us on our journey. Join our mailing list for FREE to receive the latest news and insights direct to your inbox: https://www.emjreviews.com/mailing-list/

NAICS: 511
NAICS Definition:
Employees: 107
Subsidiaries: 1
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/drug-interactions-from-the-medical-letter.jpeg
Drug Interactions from The Medical Letter
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/the-european-medical-journal.jpeg
EMJ
—
ISO 27001
ISO 27001 certification not verified
Not verified
—
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
—
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
—
GDPR
GDPR certification not verified
Not verified
—
PCI DSS
PCI DSS certification not verified
Not verified
—
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Drug Interactions from The Medical Letter
100%
Compliance Rate
0/4 Standards Verified
EMJ
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for Drug Interactions from The Medical Letter in 2025.

Incidents vs Book and Periodical Publishing Industry Average (This Year)

No incidents recorded for EMJ in 2025.

Incident History — Drug Interactions from The Medical Letter (X = Date, Y = Severity)

Drug Interactions from The Medical Letter cyber incidents detection timeline including parent company and subsidiaries

Incident History — EMJ (X = Date, Y = Severity)

EMJ cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/drug-interactions-from-the-medical-letter.jpeg
Drug Interactions from The Medical Letter
Incidents

No Incident

https://images.rankiteo.com/companyimages/the-european-medical-journal.jpeg
EMJ
Incidents

No Incident

FAQ

Drug Interactions from The Medical Letter company demonstrates a stronger AI Cybersecurity Score compared to EMJ company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, EMJ company has disclosed a higher number of cyber incidents compared to Drug Interactions from The Medical Letter company.

In the current year, EMJ company and Drug Interactions from The Medical Letter company have not reported any cyber incidents.

Neither EMJ company nor Drug Interactions from The Medical Letter company has reported experiencing a ransomware attack publicly.

Neither EMJ company nor Drug Interactions from The Medical Letter company has reported experiencing a data breach publicly.

Neither EMJ company nor Drug Interactions from The Medical Letter company has reported experiencing targeted cyberattacks publicly.

Neither Drug Interactions from The Medical Letter company nor EMJ company has reported experiencing or disclosing vulnerabilities publicly.

Neither Drug Interactions from The Medical Letter nor EMJ holds any compliance certifications.

Neither company holds any compliance certifications.

EMJ company has more subsidiaries worldwide compared to Drug Interactions from The Medical Letter company.

Neither Drug Interactions from The Medical Letter nor EMJ holds SOC 2 Type 1 certification.

Neither Drug Interactions from The Medical Letter nor EMJ holds SOC 2 Type 2 certification.

Neither Drug Interactions from The Medical Letter nor EMJ holds ISO 27001 certification.

Neither Drug Interactions from The Medical Letter nor EMJ holds PCI DSS certification.

Neither Drug Interactions from The Medical Letter nor EMJ holds HIPAA certification.

Neither Drug Interactions from The Medical Letter nor EMJ holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

ThingsBoard in versions prior to v4.2.1 allows an authenticated user to upload malicious SVG images via the "Image Gallery", leading to a Stored Cross-Site Scripting (XSS) vulnerability. The exploit can be triggered when any user accesses the public API endpoint of the malicious SVG images, or if the malicious images are embedded in an `iframe` element, during a widget creation, deployed to any page of the platform (e.g., dashboards), and accessed during normal operations. The vulnerability resides in the `ImageController`, which fails to restrict the execution of JavaScript code when an image is loaded by the user's browser. This vulnerability can lead to the execution of malicious code in the context of other users' sessions, potentially compromising their accounts and allowing unauthorized actions.

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss4
Base: 6.2
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:P/VC:N/VI:N/VA:N/SC:H/SI:L/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to to verify that the token used during the code exchange originates from the same authentication flow, which allows an authenticated user to perform account takeover via a specially crafted email address used when switching authentication methods and sending a request to the /users/login/sso/code-exchange endpoint. The vulnerability requires ExperimentalEnableAuthenticationTransfer to be enabled (default: enabled) and RequireEmailVerification to be disabled (default: disabled).

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 9.9
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
References
Description

Mattermost versions 11.0.x <= 11.0.2, 10.12.x <= 10.12.1, 10.11.x <= 10.11.4, 10.5.x <= 10.5.12 fail to sanitize team email addresses to be visible only to Team Admins, which allows any authenticated user to view team email addresses via the GET /api/v4/channels/{channel_id}/common_teams endpoint

Published
Date
2025-11-27
Updated
Date
2025-11-27
Risk Information
cvss3
Base: 4.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N
References
Description

Exposure of email service credentials to users without administrative rights in Devolutions Server.This issue affects Devolutions Server: before 2025.2.21, before 2025.3.9.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References
Description

Exposure of credentials in unintended requests in Devolutions Server.This issue affects Server: through 2025.2.20, through 2025.3.8.

Published
Date
2025-11-27
Updated
Date
2025-11-27
References